Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2026-02-27 @ 1:35 PM
Study NCT ID:
NCT01663727
Status:
COMPLETED
Last Update Posted:
2019-01-22
First Post:
2012-08-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-27
Start Date Type:
ACTUAL
Primary Completion Date:
2014-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2012-08-09
First Submit QC Date:
None
Study First Post Date:
2012-08-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-01-12
Results First Submit QC Date:
None
Results First Post Date:
2016-02-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-07
Last Update Post Date:
2019-01-22
Last Update Post Date Type:
ACTUAL